Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s stock price rose 1.2% during trading on Wednesday . The company traded as high as $1.65 and last traded at $1.65. Approximately 1,663 shares changed hands during trading, a decline of 80% from the average daily volume of 8,376 shares. The stock had previously closed at $1.63.
Orgenesis Stock Performance
The stock’s 50-day moving average is $1.59.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Read More
- Five stocks we like better than Orgenesis
- What Are Dividends? Buy the Best Dividend Stocks
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is Put Option Volume?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Canada Bond Market Holiday: How to Invest and Trade
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
